Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Pfizer recently agreed to hold off raising prices for certain drugs after Trump criticized the company and said it should be “ashamed” of the move. (Photo: Andrew Harrer/Bloomberg)

Drugmakers will likely get rid of secret discounts to middlemen that have become a focus of the U.S. drug-cost debate, Pfizer Inc. Chief Executive Officer Ian Read predicted Tuesday.

BenefitsPRO Broker Expo 2020Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.